alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 18,951–18,975 of 27,380 studies, newest first · page 759 of 1096.

January 2013 25

  1. 2013-01-07

    Delirium in an adult acute hospital population: predictors, prevalence and detection

    ✓ Peer-reviewed Getting a diagnosis BMJ open

    Key finding: Using DSM-IV criteria, 55 of 280 patients (19.6%) had delirium versus 17.6% using the CAM.

    Full summary, score breakdown and related studies → Original source

  2. 2013-01-04

    Resting state functional connectivity in preclinical Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging Biological psychiatry

    Key finding: In addition, we discuss evidence for underlying preclinical AD mechanisms, including an important relationship between resting state functional connectivity and brain metabolism and how this results in a distinctive pattern of amyloid plaque deposition in default mode network regions.

    Full summary, score breakdown and related studies → Original source

  3. 2013-01-04

    Cognitive disorders and dementia in CKD: the neglected kidney-brain axis

    ✓ Peer-reviewed How common it is Journal of the American Society of Nephrology : JASN

    Key finding: Epidemiologic data suggest that individuals at all stages of CKD have a higher risk of developing cognitive disorders and dementia.

    Full summary, score breakdown and related studies → Original source

  4. 2013-01-04

    Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples

    ✓ Peer-reviewed Genetics The Journal of biological chemistry

    Key finding: Thus, literature results are inconsistent and difficult to interpret. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2013-01-03

    Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Biochemical pharmacology

    Key finding: The associations remained significant for CSF cholesterol and 24S-hydroxycholesterol when analyses were separately performed in the AD group. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2013-01-03

    Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke

    ✓ Peer-reviewed TREM2 and immune genetics PloS one

    Key finding: Triggering receptor expressed on myeloid cells-2 (TREM2) is a microglial surface receptor involved in phagocytosis. +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2013-01-03

    Molecular neuropsychology: creation of test-specific blood biomarker algorithms

    ✓ Peer-reviewed Biomarkers Dementia and geriatric cognitive disorders

    Key finding: Prior work on the link between blood-based biomarkers and cognitive status has largely been based on dichotomous classifications rather than detailed neuropsychological functioning.

    Full summary, score breakdown and related studies → Original source

  8. 2013-01-01

    Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging

    ✓ Peer-reviewed Long-term cohort studies NeuroImage Clinical

    Key finding: Both VBA and ROI analyses revealed widespread group differences in FA and all diffusivity measures.

    Full summary, score breakdown and related studies → Original source

  9. 2013-01-01

    Diagnostic and statistical manual of mental disorders 5: A quick glance

    ✓ Peer-reviewed Risk factors Indian Journal of Psychiatry

    Key finding: The diagnostic criteria continued to result in rather frequent diagnosis of comorbidity. +1 more finding

    Full summary, score breakdown and related studies → Original source

  10. 2013 year only

    Health insurance status and the care of nursing home residents with advanced dementia

    ✓ Peer-reviewed Costs and economics JAMA internal medicine

    Key finding: Residents enrolled in managed care (n = 133) were more likely to have do-not-hospitalize orders compared with those in traditional Medicare fee for service (n = 158) (63.7% vs 50.9%; adjusted odds ratio, 1.9; 95% CI, 1.1-3.4), were less likely to be transferred to the hospital for acute illness (3.8% vs 15.7%; adjusted odds ratio, 0.2; 95% CI, 0.1-0.5), had more primary care visits per 90 days (mean [SD], 4.8 [2.6] vs 4.2 [5.0]; adjusted rate ratio, 1.3; 95% CI, 1.1-1.6), and had more nurse practitioner visits (3.0 [2.1] vs 0.8 [2.6]; adjusted rate ratio, 3.0; 95% CI, 2.2-4.1). +2 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2013 year only

    Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease : JAD

    Key finding: A significant proportion of patients with dementia with Lewy bodies (DLB) show Alzheimer's disease (AD) pathology like senile plaques and neurofibrillary tangles. +3 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2013-01-01

    Adaptive downregulation of mitochondrial function in down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Cell metabolism

    Key finding: Sustained stimulation restored mitochondrial functional parameters but increased reactive oxygen species production and cell damage, suggesting that reduced DS mitochondrial activity is an adaptive response for avoiding injury and preserving basic cellular functions. +1 more finding

    Full summary, score breakdown and related studies → Original source

  13. 2013-01-01

    Atypical aging in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Developmental disabilities research reviews

    Key finding: At present, there may be over 210,000 people with Down syndrome (DS) over the age of 55 in the United States (US) who have significant needs for augmented services due to circumstances related to ordinary and/or pathological aging.

    Full summary, score breakdown and related studies → Original source

  14. 2013-01-01

    Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders

    ✓ Peer-reviewed Digital health tools Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Medicare beneficiaries with ADRD were at a higher risk of PAHs for certain uncontrolled comorbidities and incurred higher Medicare expenditures compared with matched controls without dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2013-01-01

    Deep learning-based feature representation for AD/MCI classification

    ✓ Peer-reviewed Digital health tools Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention

    Key finding: In recent years, there has been a great interest in computer-aided diagnosis of Alzheimer's Disease (AD) and its prodromal stage, Mild Cognitive Impairment (MCI). +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2013-01-01

    Structural and functional characterization of two alpha-synuclein strains

    ✓ Peer-reviewed Brain tissue and pathology Nature communications

    Key finding: The association of protein aggregates made of a single protein with a variety of clinical phenotypes has been explained for prion diseases by the existence of different strains that propagate through the infection pathway. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2013-01-01

    Pericyte loss influences Alzheimer-like neurodegeneration in mice

    ⚠ Retracted — do not rely on it Vascular contributions Nature communications

    Key finding: Pericytes are cells in the blood-brain barrier that degenerate in Alzheimer's disease (AD), a neurological disorder associated with neurovascular dysfunction, abnormal elevation of amyloid β-peptide (Aβ), tau pathology and neuronal loss. +1 more finding

    Full summary, score breakdown and related studies → Original source

  18. 2013-01-01

    Neuroactive insecticides: targets, selectivity, resistance, and secondary effects

    ✓ Peer-reviewed Risk factors Annual review of entomology

    Key finding: Currently, the four major nerve targets are acetylcholinesterase for organophosphates and methylcarbamates, the nicotinic acetylcholine receptor for neonicotinoids, the γ-aminobutyric acid receptor/chloride channel for polychlorocyclohexanes and fiproles, and the voltage-gated sodium channel for pyrethroids and dichlorodiphenyltrichloroethane. +4 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2013-01-01

    Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease

    ✓ Peer-reviewed Risk factors Alzheimer disease and associated disorders

    Key finding: The MoCA showed consistently superior psychometric properties compared with the MMSE, and higher diagnostic accuracy to discriminate between MCI (area under the curve=0.856; 95% confidence interval, 0.796-0.904) and AD patients (area under the curve=0.980; 95% confidence interval, 0.947-0.995). +2 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2013-01-01

    Anti-inflammatory therapy in chronic disease: challenges and opportunities

    ✓ Peer-reviewed Risk factors Science (New York, N.Y.)

    Key finding: As a result, redundancy, compensatory pathways, and necessity narrow the risk:benefit ratio of anti-inflammatory drugs.

    Full summary, score breakdown and related studies → Original source

  21. 2013-01-01

    Endoplasmic reticulum dysfunction in neurological disease

    ✓ Peer-reviewed Risk factors The Lancet. Neurology

    Key finding: Endoplasmic reticulum (ER) dysfunction might have an important part to play in a range of neurological disorders, including cerebral ischaemia, sleep apnoea, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, the prion diseases, and familial encephalopathy with neuroserpin inclusion bodies. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2013-01-01

    Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease

    ✓ Peer-reviewed Drug development Current Alzheimer research

    Key finding: In the evaluation phase, the treated group showed no decreased performance in the mini-mental state examination test, in opposition to the lower scores observed for the control group during the treatment, with significant differences starting three months after the beginning of the treatment, and increasing progressively.

    Full summary, score breakdown and related studies → Original source

  23. 2013-01-01

    GSK3 and tau: two convergence points in Alzheimer's disease

    ✓ Peer-reviewed Drug development Journal of Alzheimer's disease : JAD

    Key finding: Our data suggest that progression of the tauopathy can be prevented by administration of lithium when the first signs of neuropathology appear.

    Full summary, score breakdown and related studies → Original source

  24. 2013-01-01

    Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology

    ✓ Peer-reviewed Treatments Journal of psychiatry & neuroscience : JPN

    Key finding: Alzheimer disease is the most prevalent form of dementia globally and is characterized premortem by a gradual memory loss and deterioration of higher cognitive functions and postmortem by neuritic plaques containing amyloid ß peptide and neurofibrillary tangles containing phospho-tau protein. +4 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2013-01-01

    Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study

    ✓ Peer-reviewed Treatments Journal of Alzheimer's disease : JAD

    Key finding: Responders in MMSE were significantly higher in the active group (p = 0.05). +1 more finding

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →